Explore

IPMC 2020

International Precision Medicine Conference 2020

Baltimore, United States
23 - 25 April 2020
The conference ended on 25 April 2020

Important Dates

Abstract Submission Deadline
15th November 2019
Early Bird Deadline
29th November 2019

About IPMC 2020

International Precision Medicine Conference 2020 brings together the specialists from all the aspects to meet and discuss the future of Precision Medicine in today’s world to thrive and survive with a better health and by exploring the New Era of individualized treatment through science and technology. We cordially invite you to contribute your research work and help us to shape the conference through submissions of your research abstract papers and e-posters. Scientific Sessions: Rare Diseases/Disorders and Orphan Drugs Lifestyle Medicine Cardiology and vascular medicine Nanotechnology in Personalized Medicine

Topics

Personalised medicines and drugs, Genetics & genomic medicine

Call for Papers

Magnus group extends its warm welcome to all its participants to International Precision Medicine Conference scheduled on April 23-25, 2020 at Baltimore, USA with a theme “Latest Innovations in Precision Medicine”. IPMC 2020 provides the premier interdisciplinary forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Precision medicine. The Career Guidance Workshops to the Graduates, Doctorates and Post-Doctoral Fellows. The conference program will cover a wide variety of topics relevant to the Precision medicine includes: Precision Immunotherapy, Translational medicine, Molecular diagnostics, Precision medicine in Oncology.

Recommended Precision Medicine Conferences: International Precision Medicine Conferences 2020 | Personalized Medicine Conferences | Precision Medicine. 

Keep Up to Date with PaperCrowd

Sign up and follow your favorite conferences.

We are no longer accepting conference submissions on PaperCrowd. We apologise for any inconvenience.